OP, how would you apply a similar analysis to sales post approval of LVAD indication by say June 30 2026? And how would the enrolment of the confirmatory trial affect uptake?
- Forums
- ASX - By Stock
- MSB
- Quarter 2 Ryoncil revenue projections
MSB
mesoblast limited
Add to My Watchlist
3.06%
!
$2.38

Quarter 2 Ryoncil revenue projections, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.38 |
Change
-0.075(3.06%) |
Mkt cap ! $3.039B |
Open | High | Low | Value | Volume |
$2.45 | $2.48 | $2.35 | $6.775M | 2.803M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 36996 | $2.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 34568 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 36466 | 2.370 |
31 | 95572 | 2.360 |
28 | 240319 | 2.350 |
16 | 61044 | 2.340 |
8 | 44086 | 2.330 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 44108 | 18 |
2.390 | 56447 | 26 |
2.400 | 56775 | 15 |
2.410 | 74269 | 13 |
2.420 | 308014 | 11 |
Last trade - 15.31pm 31/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |